Turkish Validation Study of Endometriosis Health Profile -30 (EHP-30) Test

• Sponsor: Kanuni Sultan Suleyman Training and Research Hospital (Other)
• Overall Status: Completed
• CT.gov ID: NCT04862364
• Collaborator: Engin Oral (Other)
• Enrollment: 228
• Location: 1
• Actual Duration (Months): 4
• Patients Per Site Per Month: 56.9

Study Details

Study Description

Brief Summary

For the Turkish validation Study of the Endometriosis Health Profile test (EHP-30) consisting of 30 questions, this 30-question test will be applied to 228 patients after 2 different translations to be applied after the translation of this 30-question test sworn translator to the patients who have been surgically diagnosed with endometriosis.

Condition or Disease	Intervention/Treatment	Phase
Endometriosis	Other: Endo Patients with Endometriosis Health Profile -30 (EHP-30) Test

Detailed Description

The appointment of the patients consists of patients who were surgically diagnosed with Endometriosis in our clinic. English and Turkish translation will be verified after 2 different sworn translators.

Study Design

• Study Type: Observational
• Actual Enrollment: 228 participants
• Observational Model: Case-Control
• Time Perspective: Prospective
• Official Title: Turkish Validation of Endometriosis Health Profile -30 (EHP-30) Test
• Actual Study Start Date: Apr 26, 2021
• Actual Primary Completion Date: Aug 20, 2021
• Actual Study Completion Date: Aug 26, 2021

Outcome Measures

Primary Outcome Measures

1. Turkish Validation of Endometriosis Health Profile -30 (EHP-30) Test [3 months]

   The Turkish validation study of the Endometriosis Health Profile -30EHP-30 test, which shows the general quality of life of endometriosis patients, will be performed and the use of Turkish language will be provided.

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 45 Years
• Sexes Eligible for Study: Female
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• being surgically diagnosed with endometriosis

• Age between 18- 45

• not being pregnant

Exclusion Criteria:

• have been diagnosed with endometriosis by ultrasound

• above 45 and under 18 years old

• use psichiatrig drugs

• being diagnosed with a psychiatric illness

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Pinar Yalcin Bahat	Istanbul	İ̇stanbul	Turkey	34000

Sponsors and Collaborators

• Kanuni Sultan Suleyman Training and Research Hospital
• Engin Oral

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Pınar Yalcin bahat, Principal Investigator, Kanuni Sultan Suleyman Training and Research Hospital
• ClinicalTrials.gov Identifier: NCT04862364
• Other Study ID Numbers: ehp-30turkishvalidation
• First Posted: Apr 28, 2021
• Last Update Posted: Aug 31, 2021
• Last Verified: Aug 1, 2021

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Endometriosis

Study Results

No Results Posted as of Aug 31, 2021